Cellectar Biosciences Inc (NASDAQ: CLRB) is 43.68% higher on its value in year-to-date trading and has touched a low of $1.30 and a high of $4.45 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CLRB stock was last observed hovering at around $3.63 in the last trading session, with the day’s gains setting it 0.35%.
Currently trading at $3.98, the stock is 4.17% and 8.07% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.76 million and changing 9.49% at the moment leaves the stock 52.07% off its SMA200. CLRB registered 180.28% gain for a year compared to 6-month gain of 56.69%. The firm has a 200-day simple moving average (SMA200) of -$0.95.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 1.02% loss in the last 1 month and extending the period to 3 months gives it a 53.08%, and is 2.84% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.00% over the week and 7.06% over the month.
Cellectar Biosciences Inc (CLRB) has around 20 employees, a market worth around $48.91M and $0.00M in sales. Distance from 52-week low is 206.15% and -10.56% from its 52-week high.
Cellectar Biosciences Inc quarterly earnings per share for the current quarter are estimated at -$1.The EPS is expected to grow by 53.22% this year.
Cellectar Biosciences Inc (CLRB) Top Institutional Holders
28 institutions hold shares in Cellectar Biosciences Inc (CLRB), with institutional investors hold 33.55% of the company’s shares. The shares outstanding are 20.74M, and float is at 11.13M with Short Float at 16.93%. Institutions hold 32.28% of the Float.
The top institutional shareholder in the company is AIGH Capital Management LLC with over 0.81 million shares valued at $1.59 million. The investor’s holdings represent 8.18% of the CLRB Shares outstanding. As of Jun 29, 2023, the second largest holder is Worth Venture Partners, Llc with 0.31 million shares valued at $0.61 million to account for 3.15% of the shares outstanding. The other top investors are Vanguard Group Inc which holds 0.17 million shares representing 1.73% and valued at over $0.34 million, while Renaissance Technologies, LLC holds 0.64% of the shares totaling 63990.0 with a market value of $0.12 million.
